1-4 of 4
Meredith Akerman
Close
Sort by
Journal Articles

Assessing the Safety of Discharging Patients Receiving High-Dose Methotrexate with Levels Greater Than 0.1 Umol/L

Elaine Xiang, Jamie Chin, Jonathan Weltz, Aaron Sango, Meredith Akerman, Michael L. Grossbard, Shella Saint Fleur-Lominy
Journal: Blood
Blood (2022) 140 (Supplement 1): 10806–10807.
https://doi.org/10.1182/blood-2022-167207
Published: 2022
Journal Articles

Evaluating the Safety of Outpatient Ramp up of Venetoclax in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Elaine Xiang, Frank Cirrone, Jamie Chin, Meredith Akerman, Shella Saint Fleur-Lominy, Maher Abdul Hay
Journal: Blood
Blood (2021) 138 (Supplement 1): 2311.
https://doi.org/10.1182/blood-2021-145057
Published: 2021
Journal Articles

Association between Clinical Presentation of Multiple Myeloma, Immunoglobulin Isotypes, and Cytogenetic Risk Groups

Ramya Muddasani, DO, Angela Ramdhanny, MD, Gabriel Lutz, MD PhD, Albert Ho, MDPhD, Meredith Akerman, PhD, Mitchel Polak, Marc Braunstein, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-135981
Published: 2020
Journal Articles

Association between Immunoglobulin Isotypes and Cytogenetic Risk Groups in Multiple Myeloma

Ramya Muddasani, DO, Albert Ho, MD PhD, Meredith Akerman, PhD, Shahidul Islam, MPH, PStat, Mitchel Polak, Jamie Andres Suarez-Londono, MD, Marc Braunstein, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5585.
https://doi.org/10.1182/blood-2018-99-118831
Published: 2018